Intellia Therapeutics Revenue, Growth & Competitor Profile

DBA INTELLIA THERAPEUTICS, INC.

Company Profile & Annual Report for Intellia Therapeutics

Access the complete profile.

Intellia Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	40 Erie Street Cambridge, MA 02139

Note: Revenues for privately held companies are statistical evaluations.


Intellia Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Intellia Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Intellia Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Intellia Therapeutics Annual Revenue and Growth Rate

Intellia Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Intellia Therapeutics's revenues are gauged from an analysis of company filings.

Intellia Therapeutics's Income Statement (based on Industry Averages)

Intellia Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Intellia Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 3, 2015	28	100%	$70 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Intellia Therapeutics is developing and marketing. Intellia Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MAGNITUDE CLINICAL TRIAL Medical treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology	03/09/2023
EXTELLIA THERAPEUTICS Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy	01/04/2016
INTELLIONS Viral-based vectors used to insert and deliver gene editing and repairing therapeutic products into human and animal genes	03/03/2015

See all trademarks and details in the Full Report.

Market Share of Intellia Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Intellia Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Intellia Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Future Competition: Intellia Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Intellia Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)